Systemic Treatment of Prostate Cancer.

Afficher d'autres versions (1)

Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple seque...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Auteur principal: Horwich, Alan
Format: Électronique eBook
Langue:Inglés
Publié: Oxford : OUP Oxford, 2010.
Collection:Oxford oncology library.
Sujets:
Prostate > Cancer > Diagnosis.
Prostate > Cancer > Treatment.
Prostate > Diseases.
Generative organs, Male > Diseases.
Genitourinary organs > Diseases.
Diseases.
Genital Neoplasms, Male
Prostatic Diseases
Genital Diseases, Male
Urogenital Neoplasms
Male Urogenital Diseases
Neoplasms by Site
Disease
Neoplasms
Prostatic Neoplasms
Female Urogenital Diseases
Prostate > Cancer > Traitement.
Prostate > Maladies.
Organes génitaux mâles > Maladies.
Appareil urogénital > Maladies.
Maladies.
illness.
disease.
HEALTH & FITNESS > Diseases > Cancer.
MEDICAL > Oncology.
Prostate > Diseases
Genitourinary organs > Diseases
Generative organs, Male > Diseases
Diseases
Accès en ligne:Texto completo
Table des matières:
  • Biological principles of hormone therapy
  • PSA as a marker of progression and response in advanced prostate cancer
  • Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer
  • Systemic treatment of recurrence after local therapies
  • First-line hormone therapy for metastatic prostate cancer
  • Second- and third-line hormone therapies
  • Chemotherapy for metastatic prostate cancer
  • Role of bisphosphonates in the systemic treatment of prostate cancer
  • Systemic isotope therapy of bone metastasis
  • Biological targets and new drug development for prostate cancer.

Documents similaires